Skip to main content
SpringerLink
Log in

Identification and Evaluation of Purity of the Parent Substance and Medicinal Form of Galanthamine Hydrobromide

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. M. D. Mashkovskii, Drugs [in Russian], Tashkent (1998), Vol. 1, p. 197–198.

    Google Scholar 

  2. Pharmacopoeial Article FS 42-Uz-0032-96. Galanthamine Hydrobromide.

  3. Pharmacopoeial Article FS 42-Uz-0050-96. Galanthamine Hydrobromide 0.5% Solution for Injections.

Download references

Author information

Authors and Affiliations

  1. Tashkent Pharmaceutical Institute, Tashkent, Uzbekistan

    I. Yu. Novikova & A. A. Tulaganov

Authors
  1. I. Yu. Novikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. A. Tulaganov
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Novikova, I.Y., Tulaganov, A.A. Identification and Evaluation of Purity of the Parent Substance and Medicinal Form of Galanthamine Hydrobromide. Pharmaceutical Chemistry Journal 36, 396–397 (2002). https://doi.org/10.1023/A:1021056500477

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021056500477

Keywords

Search

Navigation